ABBV
AbbVie, Inc. CDR (CAD Hedged) · TSX:ABBV
39.90 CAD−0.9100 −2.23%
AbbVie, Inc. CDR (CAD Hedged) (TSX:ABBV) last traded at 39.90 CAD, down 2.23% on the day. Over the past year the stock is up 24.30%. Its 52-week range is 26.89 to 41.10. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open39.74
Day range39.74 – 39.90
52-week range26.89 – 41.10
Volume651
Average volume (10 days)2.10 K
Market cap (USD)521.11 B
P/E4.93
EPS (TTM) (USD)5.69
Dividend yield2.37%
Beta (1 year)0.2840
Revenue (TTM) (USD)64.36 B
Employees57.00 K
Performance
+0.66%1 week
+10.19%1 month
+15.79%3 months
+37.59%6 months
+23.80%Year to date
+24.30%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- AbbVie Price Target Raised to $322.00/Share From $288.00 by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim maintains AbbVie at Buy, raises price target to $322 from $288TradingView · 02 Nov 2026
- Brise Pharmaceuticals Announces Global License Agreement With Abbvie To Advance The Next-Generation Of Migraine TherapiesReuters · 02 Nov 2026
- ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline ProgressZacks · 02 Nov 2026
- AbbVie Price Target Raised to $340.00/Share From $300.00 by Wells FargoDow Jones Newswires · 02 Nov 2026
- Wells Fargo maintains AbbVie at Overweight, raises price target to $340 from $300TradingView · 02 Nov 2026
- AbbVie Price Target Raised to $330.00/Share From $280.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- RBC Capital maintains AbbVie at Outperform, raises price target to $330 from $280TradingView · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.